Article citationsMore>>
Zanolli Filho, L.A., Galdez, C.R., Silva, C.A., Tavares, M.F.M., Costa, D.M. and Aurora-Prado, M.S. (2011) Development and Validation of a Simple and Rapid Capillary Zone Electrophoresis Method for Determination of NNRTI Nevirapine in Pharmaceutical Formulations. Journal of the Brazilian Chemical Society, 22, 2005-2012.
https://doi.org/10.1590/S0103-50532011001000024
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532011001000024&lng=en&nrm=iso&tlng=en
has been cited by the following article:
-
TITLE:
Development, Validation and Application of a Spectrofluorimetric Method for the Quantification of Nevirapine in Pharmaceutical Formulations Tablets and Suspensions
AUTHORS:
Lucien Murhula Namegabe, Aladin Ombeni Mahano, Serigne Omar Sarr
KEYWORDS:
Spectrofluorimetric Method, Validation Nevirapine, Sodium Hypochlorite
JOURNAL NAME:
American Journal of Analytical Chemistry,
Vol.13 No.6,
June
30,
2022
ABSTRACT: The development of the spectrofluorimetric method can be considered a promising alternative that is relatively less expensive and sufficiently reliable. In the current literature, no method for the analysis of nevirapine by spectro-fluorimetric has been reported. The proposed method is based on the transformation of naturally non-fluorescent nevirapine into a fluorescent derivative after chemical synthesis. Maximum excitation and emission wavelengths are 290 nm and 357 nm respectively. The analytical performance of the method demonstrates linearity in the concentration range 1.5 × 10-2 and 13.5 × 10-2 μg/mL with a correlation coefficient (r) greater than 0.999. The detection (LOD) and quantification (LOQ) limits found are 1.97 × 10-3 μg/mL and 5.48 × 10-3 μg/mL respectively. Recovery is achieved with 99.9% and 100.3% trueness, intra-day precision with a coefficient of variation of repeatability (CVr) of 0.99% and inter-day precision with a coefficient of variation of precision (CVR) of 1.7%. The method has been successfully applied in the analysis of 10 batches of nevirapine tablets and suspensions.